Network-based Epigenome-Wide Association Study (Network EWAS)
Network-based Epigenome-Wide Association Study · Also known as: network EWAS, network-integrated EWAS, graph-based EWAS, network-based DNA methylation analysis
Network-based EWAS extends conventional epigenome-wide association studies by overlaying differentially methylated positions or regions onto biological interaction networks — such as protein-protein interaction, co-expression, or gene regulatory networks — to identify functionally coherent epigenetic modules rather than isolated CpG hits. This integration increases statistical power for detecting weak signals and reveals coordinated epigenetic dysregulation across pathways.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use network-based EWAS when conventional EWAS yields few genome-wide-significant hits despite a plausible biological hypothesis — for instance in complex disease phenotypes with polyepigenetic architecture. It is well suited to moderate sample sizes (n = 100–500) where single-CpG power is insufficient. The method also fits multi-omics integration projects where methylation needs to be contextualized alongside transcriptomic or proteomic networks. Do not use it when sample sizes are very small (n < 50) because EWAS effect estimates become too noisy for meaningful network scoring; in those cases limit the analysis to candidate-region or targeted methylation approaches. Avoid it when the biological question specifically requires individual-CpG resolution, since network aggregation can obscure which exact sites drive a signal.
Strengths & limitations
- Increases statistical power to detect weak, distributed methylation signals by leveraging network co-regulation structure.
- Produces biologically interpretable modules rather than isolated CpG lists, facilitating mechanistic hypothesis generation.
- Reduces the multiple-testing burden compared with site-by-site correction because the unit of inference shifts to modules.
- Readily extensible to multi-omics integration by incorporating expression or protein data into the same network framework.
- Robust to phenotypic heterogeneity because shared network context can link diverse causal CpGs to a common pathway.
- Results depend heavily on the choice of reference network; different PPI or co-expression networks can yield different modules from the same data.
- Gene-annotation of CpG sites is ambiguous — a single CpG may plausibly map to multiple genes, and the mapping strategy meaningfully affects module composition.
- Network propagation methods introduce smoothing that can artificially elevate the score of highly connected hub genes regardless of true methylation association.
- Permutation-based significance testing is computationally intensive and may be inadequate when the network contains strong degree heterogeneity.
Frequently asked
How is network-based EWAS different from standard pathway enrichment analysis after EWAS?
Standard pathway enrichment (e.g., with missMethyl or gometh) tests whether significant CpGs are over-represented in predefined gene sets, treating each pathway independently. Network-based EWAS propagates the methylation signal through edge-connected interaction data, allowing subnetworks that span multiple annotated pathways to emerge and penalizing disconnected gene lists. The network approach finds modules that are spatially coherent in the interactome, not just co-annotated in a database.
Which reference network should I choose?
The choice matters. For most human disease studies, STRING (confidence score > 0.7) or BioGRID provide broad coverage. For tissue-specific analyses, using GTEx co-expression networks or tissue-specific PPI reconstructions (e.g., from GIANT) will reduce the hub-gene inflation problem and yield more biologically plausible modules. Always run a sensitivity analysis with at least two networks.
What sample size is realistic for this approach?
Because network methods partially recover power lost at the single-CpG level, they are most commonly applied in the n = 100–500 range where conventional EWAS is underpowered. Below n = 50, EWAS effect estimates are so noisy that network propagation amplifies noise rather than signal. Above n = 1000, standard EWAS typically yields enough genome-wide-significant hits to support conventional enrichment analysis without needing network integration.
Does network-based EWAS require replication?
Yes. Module-level findings from network EWAS are as prone to false discovery as any other exploratory analysis, and the additional modelling choices (network selection, propagation parameters) add researcher degrees of freedom. Independent replication in a separate cohort, or at minimum cross-validation, is necessary before reporting a module as a reliable finding.
Can I combine this with single-cell methylation data?
Emerging single-cell WGBS and scRRBS technologies produce per-cell methylation profiles, but coverage per cell is too sparse for conventional CpG-level EWAS statistics. Pseudo-bulk aggregation by cell type can produce EWAS summary statistics suitable for network projection, but dedicated single-cell network epigenomics methods are still maturing. For most practical purposes this combination remains a research frontier rather than an established protocol.
Sources
- Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011). Epigenome-wide association studies for common human diseases. Nature Reviews Genetics, 12(8), 529–541. link ↗
- Wang, S., Huang, M., Liu, C., Ma, J., & Deng, M. (2017). Network-based methods for identifying disease-related loci and epigenetic biomarkers. Briefings in Bioinformatics, 18(6), 957–968. link ↗
How to cite this page
ScholarGate. (2026, June 3). Network-based Epigenome-Wide Association Study. ScholarGate. https://scholargate.app/en/bioinformatics/network-based-epigenome-wide-association-study
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Epigenome-wide association studyBioinformatics↔ compare
- Genome-wide association studyBioinformatics↔ compare
- Multi-omics epigenome-wide association studyBioinformatics↔ compare
- Network-based GWASBioinformatics↔ compare
- Pathway Enrichment AnalysisBioinformatics↔ compare
- RNA-seq Differential ExpressionBioinformatics↔ compare